Moderna Inc. recorded a quarterly loss as vaccine sales waned and the company had an unexpected charge for a canceled ...

Cambridge, Massachusetts – home to Harvard and MIT – was the primary source of Chinese researchers who chose to head home.

Global futures markets advance as delayed tariffs ease trade concerns, with silver leading gains while S&P 500 tests record ...

Earnings season continues, and we're here to spotlight the companies expected to report their financial results on the next ...

Investing.com - U.S. stock futures were trading in a right range frollowinga positive week among major benchmark averages, with markets set to remain closed on Monday for a public holiday.

Some of the market's top nuclear stocks were down more than 20% on Monday as DeepSeek unleashed concerns about the AI trade in the US.Anton Petrus/Getty Images Nuclear energy stocks were hit ...

NEW YORK (AP) — Wall Street’s superstars tumbled Monday as a competitor from China threatens to upend the artificial-intelligence frenzy they’ve been feasting on. The S&P 500 dropped 1.5% ...

tobacco firm JTI predicts 11:44 AM UTC · Updated ago Healthcare & Pharmaceuticalscategory Moderna posts bigger loss than expected as vaccine maker scales down manufacturing 11:36 AM UTC ...

HealthDay News — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This ...

Moderna's stock roared higher on the back of news about potential AI mRNA vaccines. The company also secured a supply contract in Europe. Shares of Moderna are down 90%, and the company has a huge ...

Sales at the once-high-flying biotech will likely continue to shrink for a while. But Moderna has a new cash cow in development, along with other potential winners. The U.S. government should ...

The American pharmaceutical company Moderna is developing an mRNA-based vaccine candidate for norovirus, designated as mRNA-1403. This vaccine is designed to protect against multiple norovirus ...